DARC and D6: Silent partners in chemokine regulation?

Immunology and Cell Biology

Volumn 89, Issue 2, 2011, Pages 197-206

  Hansell, Chris A H ^a   Hurson, Catherine E ^a   Nibbs, Robert J B ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

chemokine; D6; DARC; leukocyte migration; scavenging; transcytosis

Indexed keywords

BINDING PROTEIN; CHEMOKINE BINDING PROTEIN 2; CXCL1 CHEMOKINE; DUFFY BINDING PROTEIN; INTERLEUKIN 8; MONOCYTE CHEMOTACTIC PROTEIN 1; RANTES; UNCLASSIFIED DRUG;

BLOOD GROUP DUFFY SYSTEM; BREAST CANCER; CANCER CELL CULTURE; CELL INFILTRATION; ERYTHROCYTE; GENETIC ASSOCIATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IN VITRO STUDY; IN VIVO STUDY; LUNG CANCER; MELANOMA; MOLECULE; MONOCYTOPENIA; MULTINUCLEAR CELL; MYCOBACTERIUM TUBERCULOSIS; NEUTROPENIA; NEUTROPHIL; NONHUMAN; PLASMODIUM VIVAX; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; REVIEW; SKIN INFLAMMATION; TRANSCYTOSIS; TUBERCULOSIS;

ANIMALS; CHEMOKINES; HUMANS; INFLAMMATION; MODELS, IMMUNOLOGICAL; RECEPTORS, CCR10; RECEPTORS, CELL SURFACE; TRANSCYTOSIS;

MUS;

EID: 79951924183     PISSN: 08189641     EISSN: 14401711     Source Type: Journal    
DOI: 10.1038/icb.2010.147     Document Type: Review

References (116)

1. Rot A, von Andrian UH. Chemokines in innate and adaptive host defense: basic chemokinese grammar for immune cells. Annu Rev Immunol 2004; 22: 891-928. (Pubitemid 38680444)
2. Mantovani A, Bonecchi R, Locati M. Tuning inflammation and immunity by chemokine sequestration: decoys and more. Nat Rev Immunol 2006; 6: 907-918. (Pubitemid 44851733)
3. Hansell CA, Simpson CV, Nibbs RJ. Chemokine sequestration by atypical chemokine receptors. Biochem Soc Trans 2006; 34: 1009-1013. (Pubitemid 46768978)
4. Loetscher P, Pellegrino A, Gong JH, Mattioli I, Loetscher M, Bardi G et al. The ligands of CXC chemokine receptor 3, I-TAC, Mig, and IP10, are natural antagonists for CCR3. J Biol Chem 2001; 276: 2986-2991.
5. Xanthou G, Duchesnes CE, Williams TJ, Pease JE. CCR3 functional responses are regulated by both CXCR3 and its ligands CXCL9, CXCL10 and CXCL11. Eur J Immunol 2003; 33: 2241-2250. (Pubitemid 37010042)
6. Allison AC. Genetic control of resistance to human malaria. Curr Opin Immunol 2009; 21: 499-505.
7. Tournamille C, Colin Y, Cartron JP, Le Van Kim C. Disruption of a GATA motif in the Duffy gene promoter abolishes erythroid gene expression in Duffy-negative individuals. Nat Genet 1995; 10: 224-228.
8. Mallinson G, Soo KS, Schall TJ, Pisacka M, Anstee DJ. Mutations in the erythrocyte chemokine receptor (Duffy) gene: the molecular basis of the Fya/Fyb antigens and identification of a deletion in the Duffy gene of an apparently healthy individual with the Fy(a-b-) phenotype. Br J Haematol 1995; 90: 823-829.
9. Rios M, Chaudhuri A, Mallinson G, Sausais L, Gomensoro-Garcia AE, Hannon J et al. New genotypes in Fy(a-b-) individuals: nonsense mutations (Trp to stop) in the coding sequence of either FY A or FY B. Br J Haematol 2000; 108: 448-454. (Pubitemid 30143666)
10. Horuk R, Chitnis CE, Darbonne WC, Colby TJ, Rybicki A, Hadley TJ et al. A receptor for the malarial parasite Plasmodium vivax: the erythrocyte chemokine receptor. Science 1993; 261: 1182-1184. (Pubitemid 23300887)
11. Grimberg BT, Udomsangpetch R, Xainli J, McHenry A, Panichakul T, Sattabongkot J et al. Plasmodium vivax invasion of human erythrocytes inhibited by antibodies directed against the Duffy binding protein. PLoS Med 2007; 4: e337.
12. Tung J, Primus A, Bouley AJ, Severson TF, Alberts SC, Wray GA. Evolution of a malaria resistance gene in wild primates. Nature 2009; 460: 388-391.
13. He W, Neil S, Kulkarni H, Wright E, Agan BK, Marconi VC et al. Duffy antigen receptor for chemokines mediates trans-infection of HIV-1 from red blood cells to target cells and affects HIV-AIDS susceptibility. Cell Host Microbe 2008; 4: 52-62. (Pubitemid 351944053)
14. Horne KC, Li X, Jacobson LP, Palella F, Jamieson BD, Margolick JB et al. Duffy antigen polymorphisms do not alter progression of HIV in African Americans in the MACS cohort. Cell Host Microbe 2009; 5: 415-417; author reply 418-419.
15. Julg B, Reddy S, van der Stok M, Kulkarni S, Qi Y, Bass S et al. Lack of Duffy antigen receptor for chemokines: no influence on HIV disease progression in an African treatment-naive population. Cell Host Microbe 2009; 5: 413-415; author reply 418-419.
16. Kulkarni H, Marconi VC, He W, Landrum ML, Okulicz JF, Delmar J et al. The Duffy-null state is associated with a survival advantage in leukopenic HIV-infected persons of African ancestry. Blood 2009; 114: 2783-2792.
17. Lachgar A, Jaureguiberry G, Le Buenac H, Bizzini B, Zagury JF, Rappaport J et al. Binding of HIV-1 to RBCs involves the Duffy antigen receptors for chemokines (DARC). Biomed Pharmacother 1998; 52: 436-439. (Pubitemid 29356644)
18. Walley NM, Julg B, Dickson SP, Fellay J, Ge D, Walker BD et al. The Duffy antigen receptor for chemokines null promoter variant does not influence HIV-1 acquisition or disease progression. Cell Host Microbe 2009; 5: 408-410; author reply 418-419.
19. Winkler CA, An P, Johnson R, Nelson GW, Kirk G. Expression of Duffy antigen receptor for chemokines (DARC) has no effect on HIV-1 acquisition or progression to AIDS in African Americans. Cell Host Microbe 2009; 5: 411-413; author reply 418-419.
20. Vergara C, Tsai YJ, Grant AV, Rafaels N, Gao L, Hand T et al. Gene encoding Duffy antigen/receptor for chemokines is associated with asthma and IgE in three populations. Am J Respir Crit Care Med 2008; 178: 1017-1022.
21. Nebor D, Durpes MC, Mougenel D, Mukisi-Mukaza M, Elion J, Hardy-Dessources MD et al. Association between Duffy antigen receptor for chemokines expression and levels of inflammation markers in sickle cell anemia patients. Clin Immunol 2010; 136: 116-122.
22. Mecabo G, Hayashida DY, Azevedo-Shimmoto MM, Vicari P, Arruda MM, Bordin JO et al. Duffy-negative is associated with hemolytic phenotype of sickle cell anemia. Clin Immunol 2010; 136: 458-459; author reply 460-461.
23. Afenyi-Annan A, Kail M, Combs MR, Orringer EP, Ashley-Koch A, Telen MJ. Lack of Duffy antigen expression is associated with organ damage in patients with sickle cell disease. Transfusion 2008; 48: 917-924. (Pubitemid 351614902)
24. Schnog JB, Keli SO, Pieters RA, Rojer RA, Duits AJ. Duffy phenotype does not influence the clinical severity of sickle cell disease. Clin Immunol 2000; 96: 264-268.
25. Akalin E, Neylan JF. The influence of Duffy blood group on renal allograft outcome in African Americans. Transplantation 2003; 75: 1496-1500. (Pubitemid 36597284)
26. Sticherling M, Baisch C, Bornscheuer E, Schroder JM, Christophers E. The role of the Duffy antigen-related chemokine receptor in psoriasis vulgaris. Cytokine 2002; 18: 329-333. (Pubitemid 35007480)
27. Elson JK, Beebe-Dimmer JL, Morgenstern H, Chilkuri M, Blanchard J, Lentsch AB. The Duffy antigen/receptor for chemokines (DARC) and prostate-cancer risk among Jamaican men. J Immigr Minor Health 2010 (e-pub ahead of print, doi:10.1007/s10903-010-9330-z).
28. Nalls MA, Wilson JG, Patterson NJ, Tandon A, Zmuda JM, Huntsman S et al. Admixture mapping of white cell count: genetic locus responsible for lower white blood cell count in the Health ABC and Jackson Heart studies. Am J Hum Genet 2008; 82: 81-87. (Pubitemid 351726080)
29. Reich D, Nalls MA, Kao WH, Akylbekova EL, Tandon A, Patterson N et al. Reduced neutrophil count in people of African descent is due to a regulatory variant in the Duffy antigen receptor for chemokines gene. PLoS Genet 2009; 5: e1000360.
30. Grann VR, Ziv E, Joseph CK, Neugut AI, Wei Y, Jacobson JS et al. Duffy (Fy), DARC, and neutropenia among women from the United States, Europe and the Caribbean. Br J Haematol 2008; 143: 288-293.
31. Mayr FB, Spiel AO, Leitner JM, Firbas C, Kliegel T, Jilma-Stohlawetz P et al. Duffy antigen modifies the chemokine response in human endotoxemia. Crit Care Med 2008; 36: 159-165.
32. Schnabel RB, Baumert J, Barbalic M, Dupuis J, Ellinor PT, Durda P et al. Duffy antigen receptor for chemokines (Darc) polymorphism regulates circulating concentrations of monocyte chemoattractant protein-1 and other inflammatory mediators. Blood 2010; 115: 5289-5299.
33. Jilma-Stohlawetz P, Homoncik M, Drucker C, Marsik C, Rot A, Mayr WR et al. Fy phenotype and gender determine plasma levels of monocyte chemotactic protein. Transfusion 2001; 41: 378-381. (Pubitemid 32238538)
34. Mayr FB, Spiel AO, Leitner JM, Firbas C, Schnee J, Hilbert J et al. Influence of the Duffy antigen on pharmacokinetics and pharmacodynamics of recombinant monocyte chemoattractant protein (MCP-1, CCL-2) in vivo. Int J Immunopathol Pharmacol 2009; 22: 615-625.
35. Fukuma N, Akimitsu N, Hamamoto H, Kusuhara H, Sugiyama Y, Sekimizu K. A role of the Duffy antigen for the maintenance of plasma chemokine concentrations. Biochem Biophys Res Commun 2003; 303: 137-139. (Pubitemid 36338218)
36. Darbonne WC, Rice GC, Mohler MA, Apple T, Hebert CA, Valente AJ et al. Red blood cells are a sink for interleukin 8, a leukocyte chemotaxin. J Clin Invest 1991; 88: 1362-1369.
37. Luo H, Chaudhuri A, Johnson KR, Neote K, Zbrzezna V, He Y et al. Cloning, characterization, and mapping of a murine promiscuous chemokine receptor gene: homolog of the human Duffy gene. Genome Res 1997; 7: 932-941. (Pubitemid 27445380)
38. Mei J, Liu Y, Dai N, Favara M, Greene T, Jeyaseelan S et al. CXCL5 regulates chemokine scavenging and pulmonary host defense to bacterial infection. Immunity 2010; 33: 106-117.
39. Loos T, Opdenakker G, Van Damme J, Proost P. Citrullination of CXCL8 increases this chemokine's ability to mobilize neutrophils into the blood circulation. Haematologica 2009; 94: 1346-1353.
40. Cacalano G, Lee J, Kikly K, Ryan AM, Pitts-Meek S, Hultgren B et al. Neutrophil and B cell expansion in mice that lack the murine IL-8 receptor homolog. Science 1994; 265: 682-684. (Pubitemid 24268283)
41. Serbina NV, Pamer EG. Monocyte emigration from bone marrow during bacterial infection requires signals mediated by chemokine receptor CCR2. Nat Immunol 2006; 7: 311-317.
42. Zarbock A, Bishop J, Muller H, Schmolke M, Buschmann K, Van Aken H et al. Chemokine homeostasis vs. chemokine presentation during severe acute lung injury: the other side of the Duffy antigen receptor for chemokines. Am J Physiol Lung Cell Mol Physiol 2010; 298: L462-L471.
43. Peiper SC, Wang ZX, Neote K, Martin AW, Showell HJ, Conklyn MJ et al. The Duffy antigen/receptor for chemokines (DARC) is expressed in endothelial cells of Duffy negative individuals who lack the erythrocyte receptor. J Exp Med 1995; 181: 1311-1317.
44. Middleton J, Americh L, Gayon R, Julien D, Mansat M, Mansat P et al. A comparative study of endothelial cell markers expressed in chronically inflamed human tissues: MECA-79, Duffy antigen receptor for chemokines, von Willebrand factor, CD31, CD34, CD105 and CD146. J Pathol 2005; 206: 260-268. (Pubitemid 40903190)
45. Hadley TJ, Lu ZH, Wasniowska K, Martin AW, Peiper SC, Hesselgesser J et al. Postcapillary venule endothelial cells in kidney express a multispecific chemokine receptor that is structurally and functionally identical to the erythroid isoform, which is the Duffy blood group antigen. J Clin Invest 1994; 94: 985-991.
46. Chaudhuri A, Nielsen S, Elkjaer ML, Zbrzezna V, Fang F, Pogo AO. Detection of Duffy antigen in the plasma membranes and caveolae of vascular endothelial and epithelial cells of nonerythroid organs. Blood 1997; 89: 701-712. (Pubitemid 27051707)
47. Lee JS, Frevert CW, Thorning DR, Segerer S, Alpers CE, Cartron JP et al. Enhanced expression of Duffy antigen in the lungs during suppurative pneumonia. J Histochem Cytochem 2003; 51: 159-166. (Pubitemid 36160043)
48. Liu XH, Hadley TJ, Xu L, Peiper SC, Ray PE. Up-regulation of Duffy antigen receptor expression in children with renal disease. Kidney Int 1999; 55: 1491-1500. (Pubitemid 29157149)
49. Hadley TJ, Peiper SC. From malaria to chemokine receptor: the emerging physiologic role of the Duffy blood group antigen. Blood 1997; 89: 3077-3091.
50. Horuk R, Martin A, Hesselgesser J, Hadley T, Lu ZH, Wang ZX et al. The Duffy antigen receptor for chemokines: structural analysis and expression in the brain. J Leukoc Biol 1996; 59: 29-38. (Pubitemid 26057472)
51. Gardner L, Wilson C, Patterson AM, Bresnihan B, FitzGerald O, Stone MA et al. Temporal expression pattern of Duffy antigen in rheumatoid arthritis: up-regulation in early disease. Arthritis Rheum 2006; 54: 2022-2026. (Pubitemid 43877955)
52. Patterson AM, Siddall H, Chamberlain G, Gardner L, Middleton J. Expression of the duffy antigen/receptor for chemokines (DARC) by the inflamed synovial endothelium. J Pathol 2002; 197: 108-116. (Pubitemid 34450170)
53. Segerer S, Regele H, Mac KM, Kain R, Cartron JP, Colin Y et al. The Duffy antigen receptor for chemokines is up-regulated during acute renal transplant rejection and crescentic glomerulonephritis. Kidney Int 2000; 58: 1546-1556.
54. Girard JP, Baekkevold ES, Yamanaka T, Haraldsen G, Brandtzaeg P, Amalric F. Heterogeneity of endothelial cells: the specialized phenotype of human high endothelial venules characterized by suppression subtractive hybridization. Am J Pathol 1999; 155: 2043-2055.
55. Horuk R, Martin AW, Wang Z, Schweitzer L, Gerassimides A, Guo H et al. Expression of chemokine receptors by subsets of neurons in the central nervous system. J Immunol 1997; 158: 2882-2890. (Pubitemid 127470549)
56. Wick N, Haluza D, Gurnhofer E, Raab I, Kasimir MT, Prinz M et al. Lymphatic precollectors contain a novel, specialized subpopulation of podoplanin low, CCL27-expressing lymphatic endothelial cells. Am J Pathol 2008; 173: 1202-1209.
57. Geleff S, Draganovici D, Jaksch P, Segerer S. The role of chemokine receptors in acute lung allograft rejection. Eur Respir J 2010; 35: 167-175.
58. Desbaillets I, Diserens AC, Tribolet N, Hamou MF, Van Meir EG. Upregulation of interleukin 8 by oxygen-deprived cells in glioblastoma suggests a role in leukocyte activation, chemotaxis, and angiogenesis. J Exp Med 1997; 186: 1201-1212. (Pubitemid 27469015)
59. Le Van Kim C, Tournamille C, Kroviarski Y, Cartron JP, Colin Y. The 1.35-kb and 7.5-kb Duffy mRNA isoforms are differently regulated in various regions of brain, differ by the length of their 5′ untranslated sequence, but encode the same polypeptide. Blood 1997; 90: 2851-2853. (Pubitemid 27413503)
60. Middleton J, Neil S, Wintle J, Clark-Lewis I, Moore H, Lam C et al. Transcytosis and surface presentation of IL-8 by venular endothelial cells. Cell 1997; 91: 385-395. (Pubitemid 27467969)
61. Lee JS, Wurfel MM, Matute-Bello G, Frevert CW, Rosengart MR, Ranganathan M et al. The Duffy antigen modifies systemic and local tissue chemokine responses following lipopolysaccharide stimulation. J Immunol 2006; 177: 8086-8094. (Pubitemid 44846327)
62. Kashiwazaki M, Tanaka T, Kanda H, Ebisuno Y, Izawa D, Fukuma N et al. A high endothelial venule-expressing promiscuous chemokine receptor DARC can bind inflammatory, but not lymphoid, chemokines and is dispensable for lymphocyte homing under physiological conditions. Int Immunol 2003; 15: 1219-1227. (Pubitemid 37220495)
63. Neote K, Mak JY, Kolakowski Jr LF, Schall TJ. Functional and biochemical analysis of the cloned Duffy antigen: identity with the red blood cell chemokine receptor. Blood 1994; 84: 44-52. (Pubitemid 24193803)
64. Hub E, Rot A. Binding of RANTES, MCP-1, MCP-3, and MIP-1alpha to cells in human skin. Am J Pathol 1998; 152: 749-757. (Pubitemid 28110722)
65. Pruenster M, Mudde L, Bombosi P, Dimitrova S, Zsak M, Middleton J et al. The Duffy antigen receptor for chemokines transports chemokines and supports their promigratory activity. Nat Immunol 2009; 10: 101-108.
66. Lee JS, Frevert CW, Wurfel MM, Peiper SC, Wong VA, Ballman KK et al. Duffy antigen facilitates movement of chemokine across the endothelium in vitro and promotes neutrophil transmigration in vitro and in vivo. J Immunol 2003; 170: 5244-5251. (Pubitemid 36554758)
67. Addison CL, Belperio JA, Burdick MD, Strieter RM. Overexpression of the duffy antigen receptor for chemokines (DARC) by NSCLC tumor cells results in increased tumor necrosis. BMC Cancer 2004; 4: 28.
68. Wang J, Ou ZL, Hou YF, Luo JM, Shen ZZ, Ding J et al. Enhanced expression of Duffy antigen receptor for chemokines by breast cancer cells attenuates growth and metastasis potential. Oncogene 2006; 25: 7201-7211. (Pubitemid 44764189)
69. Chakera A, Seeber RM, John AE, Eidne KA, Greaves DR. The duffy antigen/receptor for chemokines exists in an oligomeric form in living cells and functionally antagonizes CCR5 signaling through hetero-oligomerization. Mol Pharmacol 2008; 73: 1362-1370. (Pubitemid 351574826)
70. Chaudhuri A, Polyakova J, Zbrzezna V, Williams K, Gulati S, Pogo AO. Cloning of glycoprotein D cDNA, which encodes the major subunit of the Duffy blood group system and the receptor for the Plasmodium vivax malaria parasite. Proc Natl Acad Sci USA 1993; 90: 10793-10797. (Pubitemid 23347129)
71. Lacorre DA, Baekkevold ES, Garrido I, Brandtzaeg P, Haraldsen G, Amalric F et al. Plasticity of endothelial cells: rapid dedifferentiation of freshly isolated high endothelial venule endothelial cells outside the lymphoid tissue microenvironment. Blood 2004; 103: 4164-4172. (Pubitemid 38685358)
72. Luo H, Chaudhuri A, Zbrzezna V, He Y, Pogo AO. Deletion of the murine Duffy gene (Dfy) reveals that the Duffy receptor is functionally redundant. Mol Cell Biol 2000; 20: 3097-3101. (Pubitemid 30215022)
73. Edderkaoui B, Baylink DJ, Beamer WG, Wergedal JE, Porte R, Chaudhuri A et al. Identification of mouse Duffy antigen receptor for chemokines (Darc) as a BMD QTL gene. Genome Res 2007; 17: 577-585. (Pubitemid 46715507)
74. Binder NB, Niederreiter B, Hoffmann O, Stange R, Pap T, Stulnig TM et al. Estrogen-dependent and C-C chemokine receptor-2-dependent pathways determine osteoclast behavior in osteoporosis. Nat Med 2009; 15: 417-424.
75. Shen H, Schuster R, Stringer KF, Waltz SE, Lentsch AB. The Duffy antigen/receptor for chemokines (DARC) regulates prostate tumor growth. FASEB J 2006; 20: 59-64. (Pubitemid 43100476)
76. Horton LW, Yu Y, Zaja-Milatovic S, Strieter RM, Richmond A. Opposing roles of murine duffy antigen receptor for chemokine and murine CXC chemokine receptor-2 receptors in murine melanoma tumor growth. Cancer Res 2007; 67: 9791-9799. (Pubitemid 47621226)
77. Keeley EC, Mehrad B, Strieter RM. CXC chemokines in cancer angiogenesis and metastases. Adv Cancer Res 2010; 106: 91-111.
78. Bandyopadhyay S, Zhan R, Chaudhuri A, Watabe M, Pai SK, Hirota S et al. Interaction of KAI1 on tumor cells with DARC on vascular endothelium leads to metastasis suppression. Nat Med 2006; 12: 933-938. (Pubitemid 44175145)
79. Miranti CK. Controlling cell surface dynamics and signaling: how CD82/KAI1 suppresses metastasis. Cell Signal 2009; 21: 196-211.
80. Dawson TC, Lentsch AB, Wang Z, Cowhig JE, Rot A, Maeda N et al. Exaggerated response to endotoxin in mice lacking the Duffy antigen/receptor for chemokines (DARC). Blood 2000; 96: 1681-1684. (Pubitemid 30661047)
81. Reutershan J, Harry B, Chang D, Bagby GJ, Ley K. DARC on RBC limits lung injury by balancing compartmental distribution of CXC chemokines. Eur J Immunol 2009; 39: 1597-1607.
82. Zarbock A, Schmolke M, Bockhorn SG, Scharte M, Buschmann K, Ley K et al. The Duffy antigen receptor for chemokines in acute renal failure: a facilitator of renal chemokine presentation. Crit Care Med 2007; 35: 2156-2163. (Pubitemid 47326454)
83. Vielhauer V, Allam R, Lindenmeyer MT, Cohen CD, Draganovici D, Mandelbaum J et al. Efficient renal recruitment of macrophages and T cells in mice lacking the Duffy antigen/receptor for chemokines. Am J Pathol 2009; 175: 119-131.
84. Nibbs RJ, Wylie SM, Yang J, Landau NR, Graham GJ. Cloning and characterization of a novel promiscuous human beta-chemokine receptor D6. J Biol Chem 1997; 272: 32078-32083. (Pubitemid 28011878)
85. Nibbs RJ, Wylie SM, Pragnell IB, Graham GJ. Cloning and characterization of a novel murine beta chemokine receptor, D6. Comparison to three other related macrophage inflammatory protein-1alpha receptors, CCR-1, CCR-3, and CCR-5. J Biol Chem 1997; 272: 12495-12504.
86. Bonini JA, Steiner DF. Molecular cloning and expression of a novel rat CC-chemokine receptor (rCCR10rR) that binds MCP-1 and MIP-1beta with high affinity. DNA Cell Biol 1997; 16: 1023-1030. (Pubitemid 28062960)
87. McCulloch CV, Morrow V, Milasta S, Comerford I, Milligan G, Graham GJ et al. Multiple roles for the C-terminal tail of the chemokine scavenger D6. J Biol Chem 2008; 283: 7972-7982.
88. Savino B, Borroni EM, Torres NM, Proost P, Struyf S, Mortier A et al. Recognition versus adaptive up-regulation and degradation of CC chemokines by the chemokine decoy receptor D6 are determined by their N-terminal sequence. J Biol Chem 2009; 284: 26207-26215.
89. Bonecchi R, Locati M, Galliera E, Vulcano M, Sironi M, Fra AM et al. Differential recognition and scavenging of native and truncated macrophage-derived chemokine (macrophage-derived chemokine/CC chemokine ligand 22) by the D6 decoy receptor. J Immunol 2004; 172: 4972-4976. (Pubitemid 38456423)
90. Nibbs RJ, Yang J, Landau NR, Mao JH, Graham GJ. LD78beta, a non-allelic variant of human MIP-1alpha (LD78alpha), has enhanced receptor interactions and potent HIV suppressive activity. J Biol Chem 1999; 274: 17478-17483.
91. Nibbs RJ, Kriehuber E, Ponath PD, Parent D, Qin S, Campbell JD et al. The beta-chemokine receptor D6 is expressed by lymphatic endothelium and a subset of vascular tumors. Am J Pathol 2001; 158: 867-877. (Pubitemid 32221780)
92. Vetrano S, Borroni EM, Sarukhan A, Savino B, Bonecchi R, Correale C et al. The lymphatic system controls intestinal inflammation and inflammation-associated colon cancer through the chemokine decoy receptor D6. Gut 2010; 59: 197-206.
93. Di Liberto D, Locati M, Caccamo N, Vecchi A, Meraviglia S, Salerno A et al. Role of the chemokine decoy receptor D6 in balancing inflammation, immune activation, and antimicrobial resistance in Mycobacterium tuberculosis infection. J Exp Med 2008; 205: 2075-2084.
94. Wiederholt T, von Westernhagen M, Zaldivar MM, Berres ML, Schmitz P, Hellerbrand C et al. Genetic variations of the chemokine scavenger receptor D6 are associated with liver inflammation in chronic hepatitis C. Hum Immunol 2008; 69: 861-866.
95. Madigan J, Freeman DJ, Menzies F, Forrow S, Nelson SM, Young A et al. Chemokine scavenger D6 is expressed by trophoblasts and aids the survival of mouse embryos transferred into allogeneic recipients. J Immunol 2010; 184: 3202-3212.
96. Martinez de la Torre Y, Buracchi C, Borroni EM, Dupor J, Bonecchi R, Nebuloni M et al. Protection against inflammation- and autoantibody-caused fetal loss by the chemokine decoy receptor D6. Proc Natl Acad Sci USA 2007; 104: 2319-2324. (Pubitemid 46391395)
97. McKimmie CS, Fraser AR, Hansell C, Gutierrez L, Philipsen S, Connell L et al. Hemopoietic cell expression of the chemokine decoy receptor D6 is dynamic and regulated by GATA1. J Immunol 2008; 181: 3353-3363.
98. McKimmie CS, Fraser AR, Hansell C, Gutierrez L, Philipsen S, Connell L et al. Hemopoietic cell expression of the chemokine decoy receptor D6 is dynamic and regulated by GATA1. J Immunol 2008; 181: 8171-8181.
99. Bordon Y, Hansell CA, Sester DP, Clarke M, Mowat AM, Nibbs RJ. The atypical chemokine receptor D6 contributes to the development of experimental colitis. J Immunol 2009; 182: 5032-5040.
100. Berres ML, Trautwein C, Zaldivar MM, Schmitz P, Pauels K, Lira SA et al. The chemokine scavenging receptor D6 limits acute toxic liver injury in vivo. Biol Chem 2009; 390: 1039-1045.
101. Kin NW, Crawford DM, Liu J, Behrens TW, Kearney JF. DNA microarray gene expression profile of marginal zone versus follicular B cells and idiotype positive marginal zone B cells before and after immunization with Streptococcus pneumoniae. J Immunol 2008; 180: 6663-6674.
102. Martinez de la Torre Y, Locati M, Buracchi C, Dupor J, Cook DN, Bonecchi R et al. Increased inflammation in mice deficient for the chemokine decoy receptor D6. Eur J Immunol 2005; 35: 1342-1346. (Pubitemid 40691415)
103. Fra AM, Locati M, Otero K, Sironi M, Signorelli P, Massardi ML et al. Cutting edge: scavenging of inflammatory CC chemokines by the promiscuous putatively silent chemokine receptor D6. J Immunol 2003; 170: 2279-2282. (Pubitemid 36245612)
104. Galliera E, Jala VR, Trent JO, Bonecchi R, Signorelli P, Lefkowitz RJ et al. Beta-arrestin-dependent constitutive internalization of the human chemokine decoy receptor D6. J Biol Chem 2004; 279: 25590-25597. (Pubitemid 38756820)
105. Weber M, Blair E, Simpson CV, O'Hara M, Blackburn PE, Rot A et al. The chemokine receptor D6 constitutively traffics to and from the cell surface to internalize and degrade chemokines. Mol Biol Cell 2004; 15: 2492-2508. (Pubitemid 38580663)
106. Bonecchi R, Borroni EM, Anselmo A, Doni A, Savino B, Mirolo M et al. Regulation of D6 chemokine scavenging activity by ligand- and Rab11-dependent surface up-regulation. Blood 2008; 112: 493-503.
107. Graham GJ, McKimmie CS. Chemokine scavenging by D6: a movable feast? Trends Immunol 2006; 27: 381-386.
108. Jamieson T, Cook DN, Nibbs RJ, Rot A, Nixon C, McLean P et al. The chemokine receptor D6 limits the inflammatory response in vivo. Nat Immunol 2005; 6: 403-411. (Pubitemid 41716781)
109. Nibbs RJ, Gilchrist DS, King V, Ferra A, Forrow S, Hunter KD et al. The atypical chemokine receptor D6 suppresses the development of chemically induced skin tumors. J Clin Invest 2007; 117: 1884-1892. (Pubitemid 47036322)
110. Liu L, Graham GJ, Damodaran A, Hu T, Lira SA, Sasse M et al. Cutting edge: the silent chemokine receptor D6 is required for generating T cell responses that mediate experimental autoimmune encephalomyelitis. J Immunol 2006; 177: 17-21. (Pubitemid 43939108)
111. Whitehead GS, Wang T, DeGraff LM, Card JW, Lira SA, Graham GJ et al. The chemokine receptor D6 has opposing effects on allergic inflammation and airway reactivity. Am J Respir Crit Care Med 2007; 175: 243-249. (Pubitemid 46203127)
112. Maus UA, Wellmann S, Hampl C, Kuziel WA, Srivastava M, Mack M et al. CCR2-positive monocytes recruited to inflamed lungs downregulate local CCL2 chemokine levels. Am J Physiol Lung Cell Mol Physiol 2005; 288: L350-L358. (Pubitemid 40105374)
113. Cardona AE, Sasse ME, Liu L, Cardona SM, Mizutani M, Savarin C et al. Scavenging roles of chemokine receptors: chemokine receptor deficiency is associated with increased levels of ligand in circulation and tissues. Blood 2008; 112: 256-263.
114. Milligan G. Constitutive activity and inverse agonists of G protein-coupled receptors: a current perspective. Mol Pharmacol 2003; 64: 1271-1276. (Pubitemid 37532215)
115. Gardner L, Patterson AM, Ashton BA, Stone MA, Middleton J. The human Duffy antigen binds selected inflammatory but not homeostatic chemokines. Biochem Biophys Res Commun 2004; 321: 306-312. (Pubitemid 39055746)
116. Chaudhuri A, Zbrzezna V, Polyakova J, Pogo AO, Hesselgesser J, Horuk R. Expression of the Duffy antigen in K562 cells. Evidence that it is the human erythrocyte chemokine receptor. J Biol Chem 1994; 269: 7835-7838.